GlaxoSmithKline considering Serono acquisition
January 12, 2006Sales and Marketing
GlaxoSmithKline is understood to be considering the acquisition of Europe's biggest biotech company Serono, currently worth around $12 billion.Serono's chief …
Wanted: Innovative drugs
January 12, 2006Research and Development prix galien
When the UK government last month announced a series of measures to boost research and development in the NHS, its …
Programme exposes counterfeit dangers
January 12, 2006Manufacturing and Production
An undercover investigation by a TV documentary team has uncovered serious flaws in the policing of UK pharmaceutical wholesaling and …
AstraZeneca buys UK cancer research firm
January 4, 2006Research and Development
AstraZeneca has bought a small UK biotech company KuDOS which specialises in cutting edge cancer research.AstraZeneca made its name in …
Woman wins right to Herceptin trial
December 22, 2005A woman with breast cancer has been granted the right to take her PCT to court for barring access to …
Politics and Healthcare – still a volatile mix
December 22, 2005Politics and the provision of healthcare are, it is generally agreed, ultimately inseparable; but their frequent interactions are a continual …
Bird flu tops 2005 global health concerns
December 22, 2005Sales and Marketing
A survey conducted by the World Health Organisation has confirmed concerns over a possible bird flu pandemic as the year's …
Tamiflu-resistant bird flu found
December 22, 2005Sales and Marketing
A report of two cases of bird flu which proved resistant to treatment with Tamiflu have been reported in the …
FDA approves Bayer’s kidney cancer drug
December 22, 2005Sales and Marketing
Bayer's Nexavar has become the first treatment in more than ten years to receive approval in the US for the …
Pfizer lifted by Lipitor patent victory
December 20, 2005Sales and Marketing
Shares in Pfizer have risen after it saw off a patent challenge to Lipitor, its biggest selling drug.Lipitor generates around …
An Inspector Calls
December 20, 2005I have become a pharmacovigilance bore within my company – a prophet of doom. It is worse than that, because …
Right-sizing the salesforce
December 20, 2005Sales and Marketing salesforce
Can we form an impression about how good or ‘right’ a team is simply by the size of it? We …
Private sector vital for Government plans for patient choice
December 15, 2005NHS, private sector
Patients are to be given more choice in their care as the NHS undertakes an ambitious set of reforms intended …
Prexige wins approval in UK
December 15, 2005Sales and Marketing
Prexige has finally been launched in the UK after a safety review of the entire Cox-II class delayed its entrance …
Merck disappointed after jury undecided in Vioxx case
December 13, 2005Sales and Marketing
Merck said it was disappointed after a jury failed to reach a unanimous decision in the first federal court case …
AstraZeneca doubles trial size for stroke drug
December 13, 2005Research and Development AstraZeneca, stroke
Late stage clinical trials of AstraZeneca’s new stroke treatment have resumed after the company decided to double the number of …
US regulator looks to improve communication strategy
December 13, 2005Sales and Marketing
The FDA is investigating ways of improving its communication of the risks, including dangerous side-effects, linked with prescription drugs.The US …
Seven Stones wins General Electric Healthcare account
December 13, 2005Medical Communications
Specialist healthcare communications agency Seven Stones has secured a new global account with General Electric Healthcare Discovery Systems.A subsidiary of …
Shire and New River expect new ADHD launch in 2006
December 8, 2005Sales and Marketing
New River Pharmaceuticals has filed a new treatment for attention deficit hyperactivity disorder (ADHD) with US regulator the FDA.New River …
350 million needed for stem cell research
December 8, 2005Research and Development
At least £350 million extra funding is needed for UK stem cell research if it is to maintain its international …
Latest content
